LON:AZN - AstraZeneca Stock Price, News, & Analysis

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

AstraZeneca announced a dividend on Thursday, July 26th. Shareholders of record on Thursday, August 9th will be paid a dividend of GBX 68.40 per share on Monday, September 10th. This represents a yield of 1.19%. The ex-dividend date of this dividend is Thursday, August 9th. The official announcement can be accessed at this link. View AstraZeneca's Dividend History.

23 equities research analysts have issued 1-year target prices for AstraZeneca's stock. Their predictions range from GBX 4,080 to GBX 6,600. On average, they expect AstraZeneca's stock price to reach GBX 5,665.33 in the next year. This suggests that the stock has a possible downside of 5.5%. View Analyst Price Targets for AstraZeneca.

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 2 sell ratings, 7 hold ratings, 13 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AstraZeneca.

Some companies that are related to AstraZeneca include Sanofi (SAN), Bayer (BAYN), GlaxoSmithKline (GSK), BEXIMCO PHARMAC/S GDR REGS (BXP), OTSUKA HOLDINGS/ADR (OTSKY), Hutchison China MediTech (HCM), Dechra Pharmaceuticals (DPH), Mayne Pharma Group (MYX), Vectura Group (VEC), Eco Animal Health Group (EAH), Trilogy International Partners (TRL), Allergy Therapeutics (AGY), Sinclair Pharma (SPH), Pharmaxis (PXS) and NanoViricides (NNVC).

Headlines about AZN stock have trended somewhat positive recently, Accern Sentiment reports. The research group scores the sentiment of news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. AstraZeneca earned a coverage optimism score of 0.13 on Accern's scale. They also assigned news coverage about the biopharmaceutical company an impact score of 47.96 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term. View Recent Headlines for AstraZeneca.

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of AZN stock can currently be purchased for approximately GBX 5,996.

AstraZeneca has a market capitalization of £61.66 billion.

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.